“Angiotensin-converting enzyme inhibitors were associated with an increased risk of stroke outcomes (11 percent increased risk of combined fatal and nonfatal hospitalized stroke) compared with diuretics, and this effect persisted well beyond the trial period.”
This didn’t cover ARBs, which are a newer option to ACE-Inhibitors. However, it is known ARBs do have fewer side effects than ACE-Inhibitors.
As for what was in the study, the other outcomes between the three were similar, outside of stroke issues with ACE-Inhibitors.
To: Mazey; ckilmer; goodnesswins; Jane Long; BusterDog; jy8z; ProtectOurFreedom; matthew fuller; ...
The “Take Charge Of Your Health” Ping List
This high volume ping list is for health articles and studies which describe something you or your doctor, when informed, may be able to immediately implement for your benefit.
Email me to get on either the “Common/Top Issues” (20 - 25% fewer pings) or “Everything” list.
2 posted on
12/06/2023 7:14:29 PM PST by
ConservativeMind
(Trump: Befuddling Democrats, Republicans, and the Media for the benefit of the US and all mankind.)
To: ConservativeMind
I was on a beta blocker for years, developed TIAs and had monumental headaches. My doctor switched me to Losartan, much better.
3 posted on
12/07/2023 2:18:47 AM PST by
steve8714
(Evidently the Oxford comma is racist, sexist, or homophobic. You decide which.)
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson